University of Illinois at Chicago
Exemption #VLH115

Announcement of an Exempt Purchase

Award Info Published Thursday August 11, 2022

Advanced Accelerator Applications USA IncMelburn, NJ

  • Amount: An estimated $500,000
  • Terms: An estimated start date of 8/15/2022 through 8/14/2025
  • Renewals: None

Summary

Vendors

1 total
0 BEP vendors
0 VBP vendors
0 Small businesses

The University award process may be delayed up to thirty days as this award goes through a state approval process.

First published Thursday, August 11, 2022
The University awarded a contract for Supply of Radiopharmaceuticals.
This radiopharmaceutical LUTATHERA (lutetium Lu 177 dotatate) injection is indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut and hindgut neuroendocrine tumors in adults.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Without this radiopharmaceutical, UIH will not be able to provide care for the patients.

For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
Vernell Hammons
UIC Purchasing and Contract Management
809 S. Marshfield Ave.
3rd floor (MC 560)
Chicago, IL 60612
Phone: (312) 996-3409
FAX: (312) 996-3135

The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.

Documents

To obtain any of the following documents, please log into your Bulletin account.

Exemption Document

  • signedExemptionVLH115RequestforSupplyofRadiophamaceuticals.pdf (2 MB)
Log In